Senior living provider The Pennant Group (NASDAQ: PNTG) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 33.3% year on year to $278.6 million. Its non-GAAP profit of $0.32 per share was 4.9% above analysts’ consensus estimates.

Is now the time to buy PNTG? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

The Pennant Group’s first quarter was met with a positive market response as the company’s non-GAAP profit exceeded expectations, despite revenue coming in slightly below analyst forecasts. Management attributed the quarter’s performance primarily to operational improvements within newly acquired businesses, ongoing integration in the Southeast, and margin stability across both the Home Health and Senior Living segments. CEO Brent Guerisoli highlighted the company’s ability to rebound from seasonal and weather-related disruptions, noting, “We have successfully rebounded and increased total census above the levels at the time of acquisition.” Leadership development and local operational autonomy were also emphasized as key drivers of ongoing margin improvement.

Looking forward, management’s guidance is anchored by the continued integration of Southeast acquisitions, targeted margin expansion, and joint ventures with healthcare systems. The leadership team expects further progress in systems transitions and operational efficiencies as a result of leadership training and technology investments. President John Gochnour stated, “We see a lot of opportunity as transition service agreement costs roll off. As folks roll into our systems and as we improve clinical outcomes, we expect margin improvement to occur throughout the year.” The Pennant Group also anticipates incremental benefits from regulatory changes and expanded payer relationships as it completes integration efforts.

Key Insights from Management’s Remarks

Management pointed to operational execution in integration, clinical quality, and leadership development as core drivers of Q1 results, while also highlighting regional expansion and ongoing regulatory changes impacting the business.

• Southeast integration drives growth: The transition of Home Health, Hospice, and Home Care operations in Tennessee, Alabama, and Georgia is progressing through staggered waves, with early improvements in census and cost structure as the company’s systems are adopted.
• Leadership development pipeline: Pennant invested heavily in leadership training, adding over 100 new CEOs in training in 2025 and continuing to elevate local leaders in 2026, which management credits as essential for successful integration and operational consistency.
• Home Health and Hospice momentum: The Home Health and Hospice segment showed strong same-store growth, benefiting from value-based purchasing incentives, stronger referral relationships, and clinical process improvements despite a Medicare base rate reduction.
• Senior Living segment expansion: Recent acquisitions in the Phoenix area and Wisconsin, including both real estate and operating assets, have expanded Pennant’s portfolio. While initial occupancy is low, management expects significant upside as turnaround efforts take hold.
• Regulatory and payer environment: Management cited a 2.4% hospice rate increase proposal and positive payer negotiations as tailwinds, while also noting increased scrutiny on fraud, waste, and abuse in the industry—an environment Pennant believes creates new growth opportunities for compliant providers.

Drivers of Future Performance

Pennant’s outlook for 2026 is shaped by its approach to acquisition integration, targeted operational efficiencies, and a disciplined pursuit of margin expansion amid evolving regulatory and industry trends.

• Transition cost roll-off: Management expects expenses related to transition service agreements and system integrations to decrease over the next two quarters, supporting incremental operating margin gains as new acquisitions are fully integrated.
• Market and payer expansion: The company anticipates continued growth in the Southeast, with additional joint ventures and better payer contracts enhancing both scale and profitability. Investments in payer negotiation resources are expected to translate into improved reimbursement rates.
• Regulatory and macro headwinds: Management highlighted industry-wide scrutiny on fraud and abuse, increased labor costs, as well as fuel price volatility as ongoing risks. However, they believe Pennant’s compliance programs and local market strategies position the company to mitigate these headwinds and potentially capture market share from less compliant competitors.

Catalysts in Upcoming Quarters

In future quarters, our analyst team will monitor (1) the pace and effectiveness of Southeast integration, particularly as transition service costs decline, (2) improvements in occupancy and margin recovery in newly acquired Senior Living communities, and (3) the impact of evolving payer contracts and joint ventures on revenue mix. Execution on these milestones and the ability to sustain operational discipline during regulatory scrutiny will be crucial for tracking Pennant’s progress.

The Pennant Group currently trades at $34.10, up from $32.53 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.